Chiron Real Estate Inc. quarterly report, Q2 FY2020

Business context and reporting period

This is Global Medical REIT Inc.’s unaudited Form 10-Q for the quarter and six months ended June 30, 2020. The filing describes a healthcare-property REIT that acquires purpose-built facilities and leases them primarily to healthcare systems and physician groups. The request metadata names Chiron Real Estate Inc.; that does not match the registrant identified in the filing.

Financial performance and position

Amounts below are in millions of dollars unless otherwise noted.

• Rental revenue was $22.0 million in Q2 and $43.6 million for the first half. The filing attributes growth mainly to properties acquired since the comparable 2019 periods.
• Q2 consolidated net income margin was approximately 7.6%, compared with approximately 14.6% a year earlier; the filing does not present a defined operating-margin measure. Q2 net income attributable to common stockholders was $0.2 million, or $0.00 per diluted share as rounded in the filing.
• For the first half, investing activities used $76.0 million, primarily for property acquisitions; financing activities provided $58.2 million. Cash and restricted cash totaled $13.3 million at June 30, 2020, versus $7.2 million at December 31, 2019.
• At June 30, total debt, net, was $466.5 million, compared with $386.2 million at year-end. The weighted-average interest rate was 3.46%; $119.2 million of revolver borrowings were unhedged. The company reported compliance with its credit-facility covenants.
• Total assets were $966.6 million and total liabilities were $523.9 million at June 30. The filing does not provide a single current ratio or other comparable headline liquidity ratio.
• Common dividends were $0.20 per share per quarter; Series A preferred dividends accrue at 7.50% annually on the $25 liquidation preference.

Material changes versus the prior comparable period

• Q2 revenue rose $5.2 million year over year, while net income fell $0.8 million. First-half revenue increased $11.6 million, while net income was essentially unchanged.
• Higher depreciation, amortization, operating costs, management fees and interest expense reflected the larger property portfolio and higher borrowings. Results also included rent reserves of approximately $1.0 million, primarily related to one tenant, and management-internalization expense of $0.9 million in Q2 and $1.4 million in the first half.
• The company completed five acquisitions in the first half for approximately $91.3 million of gross real-estate investment additions. It reported 73 facilities and approximately 3.2 million rentable square feet at June 30.
• Common shares outstanding increased to 46.3 million from 43.8 million at year-end. The company raised $14.2 million gross through at-the-market common-stock issuance in the first half.
• The fair-value liability on interest-rate swaps rose to $21.5 million from $6.5 million at year-end; first-half other comprehensive loss was $15.0 million, largely reflecting swap fair-value changes.

Outlook, commentary, risks and unusual items

• Management said COVID-19 had not materially affected reported results, liquidity or capital resources through June 30, but emphasized substantial uncertainty. Rent deferrals were approximately $1.1 million as of July 31, expected to be collected mainly from July through December 2020; further deferrals, defaults or tenant requests for relief remain possible.
• Management cited renewed restrictions on elective procedures, reduced patient volumes, unemployment and loss of employer health insurance as risks to tenant revenues and rent collection. It also reported a dramatic decrease in its acquisition pipeline. No formal earnings or full-year financial guidance is provided.
• As of July 31, management reported approximately $128 million of cash and available credit-facility capacity and expected short-term liquidity needs to be met assuming rent deferrals remained at the stated level. That assessment depends on collections, access to financing and covenant compliance.
• Subsequent to quarter-end, the company completed its management internalization on July 9 for approximately $17.6 million after working-capital adjustments. On July 24, it increased credit-facility capacity to $600 million, subject to borrowing-base limits, and entered a related $50 million interest-rate swap.
• The company disclosed approximately $19.4 million of capital-improvement commitments, with up to approximately $7.3 million potentially due within 12 months. It also identified LIBOR transition, floating-rate debt, tenant concentration and REIT qualification as risks. No material litigation was reported.
• Beginning at the end of Q4 2020, credit-facility terms limit common distributions to 95% of AFFO. Management cautioned that future dividends remain subject to board discretion and market conditions.

Important facts for investors to verify

• Confirm the registrant identity: the provided request metadata says Chiron Real Estate Inc., but the filing is for Global Medical REIT Inc.
• Review tenant rent collections, the approximately $1.0 million rent reserve, and repayment performance on the $1.1 million of COVID-related deferrals.
• Check current borrowing availability, covenant headroom, debt maturities and exposure to unhedged variable rates; reported liquidity and debt balances are dated June or July 2020.
• Assess the cost and expected benefits of the management internalization, including the purchase price and ongoing operating costs.
• Evaluate dividend coverage and sustainability alongside AFFO, preferred dividend obligations and the new common-distribution limit.
• Verify acquisition closings and capital commitments: the filing lists post-quarter acquisitions and properties under contract, which were not all completed as of June 30.